Scaling Microcarrier-based Expansion Processes for Production of High Quality Cells

Size: px
Start display at page:

Download "Scaling Microcarrier-based Expansion Processes for Production of High Quality Cells"

Transcription

1 Scaling Microcarrier-based Expansion Processes for Production of High Quality Cells Mark S. Szczypka BioTech 2016, Wädenswil Switzerland September 5 th 2016 This presentation is the work product of Pall Corporation and no portion of this presentation may be copied, published, performed, or redistributed without the express written authority of a Pall corporate officer Pall Corporation.

2 Cell-based Medical Technologies Cell Therapies Allogeneic donor into patient Autologous Cell Therapy patient into same patient Regenerative Medicine Engineered tissues 3D Bio-printing Gene Delivery Drug Discovery and Testing Gene Delivery Live cells for pharmaceutical research Cell Therapies Adult stem cells Primary cells ipsc ES cells Regenerative Medicine Drug Discovery 2

3 Cell Numbers for Therapeutic Applications and Enabling Technology Allogeneic cell therapy Indication Patients/year Cells/year (TD 1e 9 ) (Global) (Global) Ischemic Stroke 2.00E E+15 Acute Myocardial Infarction 4.00E+06 Regenerative Medicine Indication Islets for Type I diabetes 4.00E+15 Stem Cells/patient 1B TH positive neurons for Parkinson s 2 T Xpansion 2D cell culture reactors 3 Pad Bioreactors

4 Building a Simple and Robust Cell Manufacturing Platform for Scalable Expansion of hmsc Critical components Donor tissue and methods used for isolation Cells and Medium Expansion platform Substrate for attachment Bioreactor type Ancillary technologies and processes Standardized sterile connections Holding and process containers Volume reduction methods Storage containers 4

5 Pall SoloHill Microcarriers for Cell Expansion Six Different highly characterized microcarrier types Used in large scale manufacturing processes for over 30 years Rigid cores allow for easy and rapid dissociation and high cell yields Support robust growth of many different types of human and animal cells Excellent performance in serial passage Gamma-irradiated microcarriers in single-use bags facilitate ease of use Best overall performance in independent studies for microcarrier selection* * Rafiq et al. Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactor Biotech J

6 Robust Growth of hmscs on Pall SoloHill Microcarriers Cells/mL (x 10 6 ) Bioreactor Culture Spinner Control Days of Growth Medium Exchange Cells/cm 2 (x 10 4 ) Days of Growth Bioreactor Harvest Collagen Star-Plus Cells/mL (x 10 6 ) Collagen Star-Plus Medium Exchange 2.4 B 1.3 B Excellent growth and efficient harvest of human mesenchymal stem cells (hmscs) from Pall SoloHill microcarriers in small scale bioreactors 6

7 Robust Growth of hmscs on Pall SoloHill Collagen Coated Microcarriers Adipocyte Osteocyte % Gated Cells Collagen Bioreactor Bioreactor T Flask Control Marker hmsc harvested from microcarriers retain differentiation capacity and surface marker expression 7

8 hmsc Expansion using PadReactor Platform and Pall SoloHill Microcarriers Allegro Microcarrier Delivery System (AMDS-Irradiated microcarriers) RoosterBio hmsc (liquid nitrogen stock) 6L PadMini Bioreactor Pad50 3 days 4 days Maintain PDL below 18 to 20 doublings to maintain quality and consistency 8

9 Adherent Cell Culture Solutions Microcarrier Cell Culture Low shear mixing supports cell growth on microcarriers Superior gas transfer and ph control Linear scalable bioreactors (6L to 1000L) Downscale bioreactors for PD and small scale GMP batches 9 SoloHill microcarriers, delivered ready-to-use in a single use format Sterilized by gamma irradiation Allows to directly seed bioreactors no additional preparation needed

10 RoosterBio hmsc and Medium Process parameters: 1. Cell thawed & seeded at 10,000 cells/ml or 5M per 500ml culture 2. collagen coated microcarriers 3. Media Feed added on day 3 40-fold increase in viable cell number over 1 week RoosterBio media feed (RoosterReplenish) can be used to replace media exchange during bioreactor culture Efficient hmsc detachment from microcarriers (Data generated by RoosterBio) 10

11 Small scale microcarrier passage studies P1 microcarriers Harvest P2 microcarriers 0.6 Passage 2 Cells/mL (x 10 6 ) Microcarrier (n=1) Planar culture 0.0 Day 5 11

12 Reproducible and Robust Cell Expansion in 6 Liter PadMini Bioreactor 0.60 Expansion Scheme Cells/mL (x 10 6 ) BR (n = 3) CF10 LN 2 Cell Factory (CF10) Bioreactor Process Parameters PadMini (6L) RoosterBio hmsc RoosterBio High Performance media Seed density 3000 cells/cm Day 4 Microcarrier conc. Medium exchange 10 cm 2 /ml None Supplement Day 3 Over twenty-fold expansion was reproducibly achieved in batch-fed microcarrier cultures in PadMini at 6L scale in 4 days 12

13 Generation of Billons of hmsc in Pall s Single use PadReactors in 8 days Total cells 3 days 5 days Pad Mini (6 L) Pad 50 (40L) Seed Harvest Seed Harvest 1.67E E E E+10 PDL Cell Expansion 0.17 B 28 B Cells/mL (x 10 6 ) PAD50 Reactor Day 13

14 Conclusions PadReactors used in a closed system provide an ideal singleuse bioreactor system for cell expansion Pall SoloHill microcarriers provided an excellent substrate for growth of human mesenchymal stem cells (hmsc). Cells were harvested from microcarriers using simple procedures Simplification of processes steps including use of Sterile microcarriers delivered through the AMDS in single-use bioreactors hmsc were expanded from ~170 million hmsc to 28 billion cells in 8 days in batch-fed culture on SoloHill microcarriers in Padreactors 14

15 Expansion using PadReactor Platform and Pall SoloHill Microcarriers Expedite developmental timelines for cell-based Medical technologies Provide robustness and reproducibility in single-use closed system Decrease cost of implementation hmsc 6L PadMini Bioreactor Pad50 15

16 Acknowledgements Pall Life Sciences Dave Splan RoosterBio (Cells and Media) Lye-Theng Lock Jon Rowley Jin Liu Alexandria Spruiel Kaitlynn Bayne Grishma Patel Andrew Laskowski 16

17 Thank You

Application Note USD 3086 (1) Animal Component-Free Star-Plus Microcarriers for Adherent Mammalian Cell Culture

Application Note USD 3086 (1) Animal Component-Free Star-Plus Microcarriers for Adherent Mammalian Cell Culture Application Note USD 386 (1) Animal Component-Free Star-Plus Microcarriers for Adherent Mammalian Cell Culture With the continuing move of the biopharmaceutical and cell therapy industries toward the use

More information

Application Note USD3084. Allegro Microcarrier Delivery System (AMDS)

Application Note USD3084. Allegro Microcarrier Delivery System (AMDS) Application Note USD3084 Allegro Microcarrier Delivery System (AMDS) Table of Contents 1. Introduction...3 2. Materials and Methods...3 2.1 Sterilization...3 2.2 Sterility Test...3 2.3 Microcarriers...3

More information

Results and Discussion

Results and Discussion Growth Kinetics of Human Mesenchymal Stem Cells in a 3L Single-Use, Stirred Tank Bioreactor EMD Millipore Corporation 80 Ashby Rd, Bedford, MA, 01730 www.millipore.com Human mesenchymal stem cells hold

More information

Application Note USD 2975 (1) Pall SoloHill Microcarriers in the PadReactor Single-Use Bioreactor

Application Note USD 2975 (1) Pall SoloHill Microcarriers in the PadReactor Single-Use Bioreactor Application Note USD 2975 (1) Pall SoloHill Microcarriers in the PadReactor Single-Use Bioreactor Table of Contents 1. Introduction...3 2. Materials and Methods...4 2.2 Cells and Media...4 2.3 Microcarrier

More information

Mesenchymal stem cells

Mesenchymal stem cells S e c t i o n T w o PROCESS DEVELOPMENT Expansion and Characterization of Mesenchymal Stem Cells on Pall SoloHill Microcarriers by Heather Woolls, Dave Splan, and Mark Szczypka Mesenchymal stem cells (MSCs)

More information

Rachel Legmann, PhD ISCT, October 2, 2016 Memphis, TN

Rachel Legmann, PhD ISCT, October 2, 2016 Memphis, TN Industrialization of adenoviral vector production in an icellis 500 fixed bed bioreactor for the creation of autologous insulin producing liver cells for the treatment of diabetes: From bench to clinical

More information

BD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE

BD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE BD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE As the promise of stem cell therapy grows, so does the need for reliable tools for cell expansion in both research and clinical applications.

More information

Efficient Expansion of Human Mesenchymal Stem Cells (hmscs) on Corning Enhanced Attachment Microcarriers Using a Continuous Agitation Protocol

Efficient Expansion of Human Mesenchymal Stem Cells (hmscs) on Corning Enhanced Attachment Microcarriers Using a Continuous Agitation Protocol Efficient Expansion of Human Mesenchymal Stem Cells (hmscs) on Corning Enhanced Attachment Microcarriers Using a Continuous Agitation Protocol Application Note Jennifer L. Weber, Lori E. Romeo, and Jennifer

More information

Pros and cons of different expansion systems for manufacturing of an allogeneic cell therapy

Pros and cons of different expansion systems for manufacturing of an allogeneic cell therapy Pros and cons of different expansion systems for manufacturing of an allogeneic cell therapy 7 th Technical Meeting, Newcastle, 24 September 2013 Jef Pinxteren, Manager and Head R&D ReGenesys 2013 MultiStem

More information

Application Note USD Microcarrier Mixing in PadReactor Mini Bioreactor

Application Note USD Microcarrier Mixing in PadReactor Mini Bioreactor Application Note USD 3012 Microcarrier Mixing in PadReactor Mini Bioreactor Introduction The need for microcarriers in animal cell culture applications has been enhanced by the demand to increase production

More information

Expansion of Human Mesenchymal Stem Cells Using Corning HYPER Technology Cell Culture Vessels

Expansion of Human Mesenchymal Stem Cells Using Corning HYPER Technology Cell Culture Vessels Expansion of Human Mesenchymal Stem Cells Using Corning HYPER Technology Cell Culture Vessels SnAPPshots A brief technical report from the Corning Development Group Ana Maria P. Pardo and Mark E. Rothenberg,

More information

Regenerative Medicine and Stem Cell Therapies

Regenerative Medicine and Stem Cell Therapies Regenerative Medicine and Stem Cell Therapies Regenerative Medicine Major component of successful regenerated / tissue engineered organs Scaffolds A critical element is the binding of the repopulating

More information

PRIME-XV Cell Therapy Products by

PRIME-XV Cell Therapy Products by PRIME-XV Cell Therapy Products by Product List 2017 TRINOVA BIOCHEM now distributes the PRIME-XV Cell Therapy line by Irvine Scientific in Germany, Austria and Switzerland. Irvine Scientific is a worldwide

More information

Cell Characterization: Developing Assays to Address the Biological Parameters of Identity and Potency

Cell Characterization: Developing Assays to Address the Biological Parameters of Identity and Potency Cell Characterization: Developing Assays to Address the Biological Parameters of Identity and Potency Jessica Carmen Ph.D and Jon Rowley Ph.D., LBS-TCS, May 2011 Disclaimer Certain matters discussed in

More information

PRIME-XV Cell Therapy Products by

PRIME-XV Cell Therapy Products by PRIME-XV Cell Therapy Products by Product List 2017 TRINOVA BIOCHEM now distributes the PRIME-XV Cell Therapy line by Irvine Scientific in Germany, Austria and Switzerland. Irvine Scientific is a worldwide

More information

Optimizing the HyPerforma Single-Use Bioreactor for adherent cell culture on microcarriers

Optimizing the HyPerforma Single-Use Bioreactor for adherent cell culture on microcarriers APPLICATION NOTE Harvestainer BPC for microcarrier bead separation Optimizing the HyPerforma Single-Use Bioreactor for adherent cell culture on microcarriers Introduction The scale-up of culture of adherent

More information

Optimizing the HyPerforma Single-Use Bioreactor for adherent cell culture on microcarriers

Optimizing the HyPerforma Single-Use Bioreactor for adherent cell culture on microcarriers APPLICATION NOTE Harvestainer BPC for microcarrier bead separation Optimizing the HyPerforma Single-Use Bioreactor for adherent cell culture on microcarriers Introduction The scale-up of culture of adherent

More information

Expansion of Human Mesenchymal Stem Cells Using Corning HYPER Technology Cell Culture Vessels

Expansion of Human Mesenchymal Stem Cells Using Corning HYPER Technology Cell Culture Vessels Expansion of Human Mesenchymal Stem Cells Using Corning HYPER Technology Cell Culture Vessels SnAPPshots A brief technical report from the Corning Development Group Introduction Ana Maria P. Pardo and

More information

Culture of human mesenchymal stem cells in Nunc Cell Factory systems

Culture of human mesenchymal stem cells in Nunc Cell Factory systems APPLICATION NOTE Cell Factory systems Culture of human mesenchymal stem cells in Nunc Cell Factory systems Key words: Cell culture, cell culture scale-up, Nunc Cell Factory system, hmsc, expansion and

More information

Mesenchymal Stromal Cells Large-scale Culture

Mesenchymal Stromal Cells Large-scale Culture Mesenchymal Stromal Cells Large-scale Culture Adrian Gee Center for Cell & Gene Therapy Baylor College of Medicine Houston, Texas Hanley et al: Efficient manufacturing of therapeutic mesenchymal stromal

More information

Parameters to Consider When Expanding Cells on Corning Microcarriers

Parameters to Consider When Expanding Cells on Corning Microcarriers Parameters to Consider When Expanding Cells on Corning Microcarriers Application Note Katherine E. Strathearn, Ph.D. and Ana Maria P. Pardo Corning Incorporated, Life Sciences Kennebunk, Maine 04043 Introduction

More information

Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs)

Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs) Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs) Wei Wei Ph.D Center for Drug Evaluation, National Medical Products Administration (CDE,NMPA) 2018/12/04 Tokyo

More information

Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL

Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL Outcomes in Mesenchymal Stem Cell Manufacturing Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL Background HCTL established in 1992 to support BMT programs of Mayo

More information

Cellartis MSC Xeno-Free Culture Medium

Cellartis MSC Xeno-Free Culture Medium Cat. # Y50200 For Research Use Cellartis MSC Xeno-Free Culture Medium Product Manual Table of Contents I. Description... 3 II. Contents... 3 III. Storage... 3 IV. Precautions... 3 V. Materials Required

More information

Large-scale production of human mesenchymal stem cells for clinical applications

Large-scale production of human mesenchymal stem cells for clinical applications Large-scale production of human mesenchymal stem cells for clinical applications Biotechnology and Applied Biochemistry Sunghoon Jung, 1 Krishna M. Panchalingam, 1 Reynold D. Wuerth, 1 Lawrence Rosenberg,

More information

Application Note USD 2974 (2) Expansion of Vero Cells on Hillex II Microcarriers via Serial Passage in Stirred Vessels

Application Note USD 2974 (2) Expansion of Vero Cells on Hillex II Microcarriers via Serial Passage in Stirred Vessels Application Note USD 2974 (2) Expansion of Vero Cells on Hillex II Microcarriers via Serial Passage in Stirred Vessels Table of Contents 1. Introduction...3 2. Materials and Methods...4 2.1 Spinner Culture...4

More information

Allen Chen, Yu Ming Lim, Shaul Reuveny and Steve Oh

Allen Chen, Yu Ming Lim, Shaul Reuveny and Steve Oh EXPANSION AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS TO NEURAL PROGENITORS: A SIMPLIFIED BIOREACTOR PROCESS REPLACING NOGGIN WITH 2 SMALL MOLECULES Allen Chen, Yu Ming Lim, Shaul Reuveny and Steve

More information

Challenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies

Challenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies Challenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies ISCT 2011 Annual Meeting Rotterdam, The Netherlands May 18 21, 2011 BioProcess Technology Consultants www.bptc.com

More information

Mesenchymal Stem Cells

Mesenchymal Stem Cells Mesenchymal Stem Cells Instruction Manual Product Size Catalog Number from Bone Marrow (hmsc-bm) from Umbilical Cord Matrix (hmsc-uc) from Adipose Tissue (hmsc-at) 500,000 cryopreserved cells 500,000 proliferating

More information

Stem Cells, Regenerative Medicine and cgmp (GTP)

Stem Cells, Regenerative Medicine and cgmp (GTP) Stem Cells, Regenerative Medicine and cgmp (GTP) Encompass Stem cell based therapies activities Collection source Purification Isolation from other cell types if needed Manipulation Minimal vs Moderate

More information

BalanCD HEK293 SYSTEM

BalanCD HEK293 SYSTEM BalanCD HEK293 SYSTEM Maximize productivity in suspension cultures Versatile formulation supports transfection and production including: - Rapid, scalable production of viral vectors - Use the same system

More information

Welcome to the Spring 2017 Newsletter for the EU Project AUTOSTEM

Welcome to the Spring 2017 Newsletter for the EU Project AUTOSTEM Development of closed, scalable and AUTOmated robotic systems for therapeutic STEM cell manufacturing: aseptic systems from Donor-to-Patient Welcome to the Spring 2017 Newsletter for the EU Project AUTOSTEM

More information

BalanCD HEK293 SYSTEM

BalanCD HEK293 SYSTEM BalanCD HEK293 SYSTEM Maximize productivity in suspension cultures Versatile formulation supports transfection and production including: - Rapid, scalable production of viral vectors - Use the same system

More information

Stem cell transfection guide

Stem cell transfection guide APPLICATION NOTE Stem cell transfection guide Gene delivery solutions Introduction Stem cells continue to show immense promise for the future of regenerative medicine and personalized therapeutic treatments.

More information

Application Note. Introduction. Kerry Thompson, Jeff Partridge, Paula Flaherty, Susan Qian, and Deepa Saxena

Application Note. Introduction. Kerry Thompson, Jeff Partridge, Paula Flaherty, Susan Qian, and Deepa Saxena Page 1 BD PureCoat ECM Mimetic Cultureware Fibronectin Peptide: Novel Synthetic, Animalfree Surface for Culture of Human Bone Marrow-derived Mesenchymal Stem Cells Kerry Thompson, Jeff Partridge, Paula

More information

Devices and Manufacturing Equipment Used for Production of Immune Cell Therapy and Cell Expansion: Scientific/User Issues

Devices and Manufacturing Equipment Used for Production of Immune Cell Therapy and Cell Expansion: Scientific/User Issues Devices and Manufacturing Equipment Used for Production of Immune Cell Therapy and Cell Expansion: Scientific/User Issues Bruce Levine, Ph.D. Department of Pathology and Laboratory Medicine University

More information

SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website]

SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website] SCM Lifescience [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea 22332 [Website] http://www.scmlifescience.com COMPANY PROFILE [Industry] SCM Lifescience is a research-based biopharmaceutical company

More information

Amsterdam, the Netherlands 29 March 2018

Amsterdam, the Netherlands 29 March 2018 Esperite (ESP), The Cell Factory presents preclinical results on the new products of the 2 nd generation EV s drugs for treatment of inflammatory diseases Esperite with its biotech company The Cell Factory

More information

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

All quality control test results are reported on a lot specific Certificate of Analysis which is available at   or upon request. PRIME-XV NPC Expansion XSFM PRIME-XV NPC Expansion XSFM is a xeno-and serum-free medium optimized for the cultivation and expansion of neural progenitor cells (NPC) that are able to maintain their ability

More information

Regulatory Perspectives of Japan

Regulatory Perspectives of Japan International Alliance for Biological Standardization (IABS) Challenge Toward Sound Scientific Regulation of Cell Therapy Products at Kyoto International Conference Center, Kyoto, Japan Regulatory Perspectives

More information

Improved conventional practices of the pharma industry serving Cost of Goods of Autologous Cell Therapy

Improved conventional practices of the pharma industry serving Cost of Goods of Autologous Cell Therapy Tony Donolato Improved conventional practices of the pharma industry serving Cost of Goods of Autologous Cell Therapy Case Study: an Autonomous Tailor Made Isolator salamanderu: what we do? Regenerate

More information

A Novel Method for the Expansion of Mesenchymal Stem Cells using a New Brunswick S41i CO 2

A Novel Method for the Expansion of Mesenchymal Stem Cells using a New Brunswick S41i CO 2 APPLICATION NOTE No. 259 I September 2013 A Novel Method for the Expansion of Mesenchymal Stem Cells using a New Brunswick S41i CO 2 Incubator Shaker Khandaker Siddiquee and Ma Sha, Eppendorf Inc., Enfield,

More information

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

All quality control test results are reported on a lot specific Certificate of Analysis which is available at   or upon request. PRIME-XV Neural Basal Medium PRIME-XV Neural Basal Medium is a chemically-defined basal medium optimized for the culture and maintenance of neuronal cells when supplemented with PRIME-XV IS21 Supplement

More information

Cortical Neural Induction Kit. Protocol version 1.0

Cortical Neural Induction Kit. Protocol version 1.0 Cortical Neural Induction Kit Protocol version 1.0 Protocol version 1.0 Table of Contents Product Information 2 Preparation of Reagents 3 Protocol Overview 4 Seeding ipscs 4 Cortical Neural Induction

More information

Harvesting Technology Guide for mab Processes. Accelerated process development through the identification of optimal platform solutions

Harvesting Technology Guide for mab Processes. Accelerated process development through the identification of optimal platform solutions Harvesting Technology Guide for mab Processes Accelerated process development through the identification of optimal platform solutions 3 Accelerate Your Process Development Your guide to cell harvesting

More information

Genome Edited ipscs APOE -/- Knockout

Genome Edited ipscs APOE -/- Knockout Applied StemCell, Inc. (866) 497-4180 www.appliedstemcell.com Datasheet Genome Edited ipscs APOE -/- Knockout Product Information Catalog Number Description Amount Parental Cell Line Gene Knockout Generated

More information

Stem cells for therapeutic use

Stem cells for therapeutic use Transition to an industrial scale of human stem cell production for therapeutic use by Bruno JARRY, Jean-François STOLTZ and Raymond ARDAILLOU on behalf of a working group joining Academy of Technologies

More information

Mammalian Expression Platform

Mammalian Expression Platform Mammalian Expression Platform Partners for Life Advancing tomorrow s medicines w Your CDMO partner for biologics and advanced therapies Good science, experience and a quality driven approach Line/Strain

More information

Case Study: Examples Relating to the Quality Control of Cell-based Products

Case Study: Examples Relating to the Quality Control of Cell-based Products Case Study: Examples Relating to the Quality Control of Cell-based Products CMC Strategy Forum Japan 2014 Yuuki Miyatake1), 2) 1) TEIJIN PHARMA LIMITED 2) Japan Pharmaceutical Manufacturers Association

More information

Use of the XCell ATF in the Manufacture of Suspension Lentiviral Vector

Use of the XCell ATF in the Manufacture of Suspension Lentiviral Vector Use of the XCell ATF in the Manufacture of Suspension Lentiviral Vector Jesse Milling 20 June 2017 Nasdaq : BLUE bluebird bio: Why We Do What We Do Ethan Aidan Cameron Our Vision Make Hope a Reality Seeking

More information

Application Note USD Pall SoloHill Animal Protein-Free Microcarriers for Dengue Virus Production

Application Note USD Pall SoloHill Animal Protein-Free Microcarriers for Dengue Virus Production Application Note USD 8 Pall SoloHill Animal Protein-Free Microcarriers for Dengue Virus Production Introduction Microcarrier cultures have a long and successful record for use in the large-scale production

More information

Cell and gene therapy: scaling up and moving to mass production

Cell and gene therapy: scaling up and moving to mass production EDITORIAL Cell and gene therapy: scaling up and moving to mass production Nigel Whittle In order to fulfil the promise of cell therapy, it is important that manufacture of these therapies can be industrialized

More information

Getting to the Factory of the Future

Getting to the Factory of the Future Patient-Specific Cell Therapy Getting to the Factory of the Future Robert A. Preti, PhD Chief Executive Officer and President, PCT General Manager, Global Regenerative Medicine Business Sector, Hitachi

More information

Human Skeletal Muscle Progenitor Cells. Protocol version 2.0

Human Skeletal Muscle Progenitor Cells. Protocol version 2.0 Human Skeletal Muscle Progenitor Cells Protocol version 2.0 Protocol version 2.0 Table of Contents Human Skeletal Muscle Cells 2 Recommendations 2 Preparation of Reagents 2 Recombinant Human FGF2 Reconstitution

More information

BD Resurge Media Supplements Chemically Defined. Protein Free. Animal Free.

BD Resurge Media Supplements Chemically Defined. Protein Free. Animal Free. D Resurge Media Supplements Chemically Defined. Protein Free. nimal Free. Overview Cell-based production of active pharmaceutical ingredients generally requires supplementation of cell culture media to

More information

Application of Disposable Technologies in Biopharmaceutical Manufacturing

Application of Disposable Technologies in Biopharmaceutical Manufacturing BMD Summit, Disposables for Biopharm Production 13th December 2005 Reston, VA, USA Application of Disposable Technologies in Biopharmaceutical Manufacturing Martin Wrankmore, Continuous Improvement Lead,

More information

NEW! CHOgro Expression System

NEW! CHOgro Expression System NEW! CHOgro Expression System At Mirus Bio, we know it s all about expression. Introducing the new CHOgro Expression System, a transient transfection platform that finally gets high protein titers with

More information

Stem Cells and Cell Culture Developments Within ThermoFisher Scientific

Stem Cells and Cell Culture Developments Within ThermoFisher Scientific The world leader in serving science Stem Cells and Cell Culture Developments Within ThermoFisher Scientific Katrina Kidd European Application Scientist Cellomics ThermoFisher Scientific A Typical Life

More information

APPROACHES TO IMPROVING THE PERFORMANCE OF MAMMALIAN CELL CULTURES FOR PROTEIN PRODUCTION

APPROACHES TO IMPROVING THE PERFORMANCE OF MAMMALIAN CELL CULTURES FOR PROTEIN PRODUCTION BioLOGIC USA BOSTON, 20 th OCTOBER 2004 APPROACHES TO IMPROVING THE PERFORMANCE OF MAMMALIAN CELL CULTURES FOR PROTEIN PRODUCTION Dr Robert Gay Lonza Biologics 2004 The Challenge of the MAb Market Global

More information

Cambrex Cell Therapy. Buckingham Research Conference Call

Cambrex Cell Therapy. Buckingham Research Conference Call Cambrex Cell Therapy Buckingham Research Conference Call April 14, 2005 Safe Harbor Statement Today s presentation and discussion will contain forward-looking statements including statements regarding

More information

Human Mesenchymal Stem Cell Growth on Corning Denatured Collagen Dissolvable Microcarriers in a 5L Bioreactor

Human Mesenchymal Stem Cell Growth on Corning Denatured Collagen Dissolvable Microcarriers in a 5L Bioreactor Human Mesenchymal Stem Cell Growth on Corning Denatured Collagen Dissolvable Microcarriers in a 5L Bioreactor Application Note Jennifer Weber, Lori Romeo, and Paula Dolley-Sonneville Corning Incorporated,

More information

Validation of Cytodex Gamma microcarrier-based virus production in single-use bioreactor systems

Validation of Cytodex Gamma microcarrier-based virus production in single-use bioreactor systems GE Healthcare Validation of Cytodex Gamma microcarrier-based virus production in single-use bioreactor systems A majority of cell lines commonly used for viral vaccine production are anchorage-dependent

More information

REMEDiE Project London 7-8 May 2009 European Policies and Priorities for Stem Cell Research

REMEDiE Project London 7-8 May 2009 European Policies and Priorities for Stem Cell Research REMEDiE Project London 7-8 May 2009 European Policies and Priorities for Stem Cell Research Charles Kessler European Commission DG Research, Health Directorate Outline of presentation Main features of

More information

Longevity Leaders Conference. February 4, 2019

Longevity Leaders Conference. February 4, 2019 Longevity Leaders Conference February 4, 2019 Forward Looking Statements The matters discussed in this presentation include forward looking statements which are subject to various risks, uncertainties,

More information

The NYSCF Research Institute

The NYSCF Research Institute Regenerative Medicine Research Update Susan L. Solomon The NYSCF Research Institute New York Pharma Forum February 25, 2016 Regenerative Medicine Research Regenerative medicine uses laboratory grown human

More information

Serum-Free, Xeno-Free Differentiation Media. for Human Mesenchymal Stem Cells

Serum-Free, Xeno-Free Differentiation Media. for Human Mesenchymal Stem Cells Serum-Free, Xeno-Free Differentiation Media for Human Mesenchymal Stem Cells MSC go Osteogenic XF MSC go rapid Osteogenic XF MSC go Chondrogenic XF MSC go Adipogenic XF For superior adipogenesis, osteogenesis

More information

A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody.

A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody. A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody. Jeremy M Tong (presenting), Mark S Kettel, Edward M Perry, David J Pain, David M Valentine,

More information

Editorial Manufacturing Cells for Clinical Use

Editorial Manufacturing Cells for Clinical Use Stem Cells International Volume 2016, Article ID 1750697, 5 pages http://dx.doi.org/10.1155/2016/1750697 Editorial Manufacturing Cells for Clinical Use Mark L. Weiss, 1 Mahendra S. Rao, 2 Robert Deans,

More information

Critically Evaluating the Benefits of Automation in Commercial- Scale Manufacture

Critically Evaluating the Benefits of Automation in Commercial- Scale Manufacture AUTOMATION OF CELL AND GENE THERAPY MANUFACTURING: FROM VEIN TO VEIN INNOVATOR INSIGHT Critically Evaluating the Benefits of Automation in Commercial- Scale Manufacture Nina Bauer leads Lonza s Autologous

More information

BioWhittaker Specialty Media Maximize Your Cell Growth and Productivity

BioWhittaker Specialty Media Maximize Your Cell Growth and Productivity BioResearch BioWhittaker Specialty Media Maximize Your Cell Growth and Productivity BioWhittaker Specialty Media Cell Culture Applications BioResearch BioWhittaker Specialty Media Maximize Your Cell Growth

More information

Scale-Up Solutions for Cell Therapy and. Bioprocess

Scale-Up Solutions for Cell Therapy and. Bioprocess Scale-Up Solutions for Cell Therapy and Bioprocess Store Cell Acquisition Bioprocess Solutions Media Prep Bioproduction Buffer & Seed & Expand Corning is built upon a foundation of innovation and manu

More information

Cell-based therapies in tissue engineering and regenerative medicine (TE/RM)

Cell-based therapies in tissue engineering and regenerative medicine (TE/RM) Cell-based therapies in tissue engineering and regenerative medicine (TE/RM) Pamela Gehron Robey, Ph.D. Craniofacial and Skeletal Diseases Branch National Institutes of Dental and Craniofacial Research

More information

Andrew Finnerty General Manager - CCMI

Andrew Finnerty General Manager - CCMI Andrew Finnerty General Manager - CCMI Manufacturing Human Mesenchymal Stem Cells for Clinical Trials Quality Considerations Biopharma and Pharma RQA Regional Forum Bioclin Laboratories, Athlone 13 May

More information

Advancing Manufacturing for Advanced Therapies

Advancing Manufacturing for Advanced Therapies Advancing Manufacturing for Advanced Therapies Peter Marks, MD, PhD Center For Biologics Evaluation and Research, FDA CASSS Cell & Gene Therapy Symposium July 10, 2018 Overview Cell and gene therapy products

More information

Cell-based therapies hold

Cell-based therapies hold B i o P r o c e s s TECHNICAL Single-Use Bioreactors and Microcarriers Scalable Technology for Cell-Based Therapies by Mark Szczypka, David Splan, Heather Woolls, and Harvey Brandwein Cell-based therapies

More information

CONFERENCE EXCLUSIVE. Innovative Disposable Bioreactors For Membrane Protein Production Based on the Tide Principle

CONFERENCE EXCLUSIVE. Innovative Disposable Bioreactors For Membrane Protein Production Based on the Tide Principle CONFERENCE EXCLUSIVE Innovative Disposable Bioreactors For Membrane Protein Production Based on the Tide Principle By LEWIS HO Membrane proteins such as herg (human Ether-a-gogo Related Gene) and GPCRs

More information

Human Bone Marrow Derived Mesenchymal Stem Cell (MSC) Care Manual

Human Bone Marrow Derived Mesenchymal Stem Cell (MSC) Care Manual Human Bone Marrow Derived Mesenchymal Stem Cell (MSC) Care Manual INSTRUCTION MANUAL ZBM0101.001 SHIPPING CONDITIONS Human Bone Marrow Derived MSC (HBMMSC-F) Orders are delivered via Federal Express courier.

More information

Human Skeletal Muscle Cells. Protocol version 2.0

Human Skeletal Muscle Cells. Protocol version 2.0 Human Skeletal Muscle Cells Protocol version 2.0 Protocol version 2.0 Table of Contents Human Skeletal Muscle Cells 2 Recommendations 2 Preparation of Reagents 2 Recombinant Human FGF2 Reconstitution

More information

2015 State of the Science in Transfusion Medicine Overarching themes and specific questions for RBCs What s in the [RBC] bag? Identify and quantify the components of RBC products to improve the quality,

More information

STEMdiff Mesenchymal Progenitor Kit

STEMdiff Mesenchymal Progenitor Kit Defined culture kit for derivation and expansion of mesenchymal progenitor cells Catalog #05240 1 Kit Product Description STEMdiff Mesenchymal Progenitor Kit is a defined culture kit consisting of animal

More information

Lineage-specific Reporter Knock-in ipscs: MAP2-Nanoluc-Halotag ipsc (Heterozygous)

Lineage-specific Reporter Knock-in ipscs: MAP2-Nanoluc-Halotag ipsc (Heterozygous) Lineage-specific Reporter Knock-in ipscs: MAP2-Nanoluc-Halotag ipsc (Heterozygous) Applied StemCell, Inc. (866) 497-4180 www.appliedstemcell.com Datasheet Product Information Catalog Number Description

More information

Application Note USD3011. Influenza Virus Production with Adherent VERO Cells in PadReactor Mini Bioreactor

Application Note USD3011. Influenza Virus Production with Adherent VERO Cells in PadReactor Mini Bioreactor Application Note USD311 Influenza Virus Production with Adherent VERO Cells in Reactor Mini Bioreactor Introduction Single-use solutions are found in many applications as they offer straightforward alternatives

More information

Lineage-specific Reporter Knock-in ipscs: MAP2-Nanoluc-Halotag ipsc (Heterozygous)

Lineage-specific Reporter Knock-in ipscs: MAP2-Nanoluc-Halotag ipsc (Heterozygous) Lineage-specific Reporter Knock-in ipscs: MAP2-Nanoluc-Halotag ipsc (Heterozygous) Applied StemCell, Inc. (866) 497-4180 www.appliedstemcell.com Datasheet Product Information Catalog Number Description

More information

Realizing the Future that Regenerative Medicine Will Open

Realizing the Future that Regenerative Medicine Will Open 470 Hitachi Review Vol. 65 (2016), No. 9 Featured Articles Realizing the Future that Regenerative Medicine Will Open Shizu Takeda, Ph.D. OVERVIEW: Regenerative medicine is an innovative approach to medicine

More information

Mixing theory for culture and harvest in bioreactors of human mesenchymal stem cells on microcarriers

Mixing theory for culture and harvest in bioreactors of human mesenchymal stem cells on microcarriers Loughborough University Institutional Repository Mixing theory for culture and harvest in bioreactors of human mesenchymal stem cells on microcarriers his item was submitted to Loughborough University's

More information

Protocol Using the Reprogramming Ecotropic Retrovirus Set: Mouse OSKM to Reprogram MEFs into ips Cells

Protocol Using the Reprogramming Ecotropic Retrovirus Set: Mouse OSKM to Reprogram MEFs into ips Cells STEMGENT Page 1 OVERVIEW The following protocol describes the reprogramming of one well of mouse embryonic fibroblast (MEF) cells into induced pluripotent stem (ips) cells in a 6-well format. Transduction

More information

FectoCHO Expression system DNA transfection kit for protein production PROTOCOL

FectoCHO Expression system DNA transfection kit for protein production PROTOCOL FectoCHO Expression system DNA transfection kit for protein production DESCRIPTION PROTOCOL FectoCHO Expression system is a three-component kit that includes FectoPRO transfection reagent, FectoPRO Booster

More information

Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions

Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions For reprint orders, please contact: reprints@futuremedicine.com Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions Aim: To develop a decisional tool to identify

More information

Whitepaper. Small Molecule Vs Cell Therapy Clinical Trial Supply Chain. Martin Lamb, Executive Vice President for Sales and Marketing

Whitepaper. Small Molecule Vs Cell Therapy Clinical Trial Supply Chain.  Martin Lamb, Executive Vice President for Sales and Marketing Small Molecule Vs Cell Therapy Clinical Trial Supply Chain Page 1 Whitepaper Small Molecule Vs Cell Therapy Clinical Trial Supply Chain Martin Lamb, Executive Vice President for Sales and Marketing Small

More information

PMDA s Efforts - Regulation and Innovation. Takao YAMORI, Ph.D. Executive Director Pharmaceuticals and Medical Devices Agency (PMDA)

PMDA s Efforts - Regulation and Innovation. Takao YAMORI, Ph.D. Executive Director Pharmaceuticals and Medical Devices Agency (PMDA) PMDA s Efforts - Regulation and Innovation Takao YAMORI, Ph.D. Executive Director Pharmaceuticals and Medical Devices Agency (PMDA) 1 Disclaimer The views and opinions expressed in the following PowerPoint

More information

CHOgro Expression System

CHOgro Expression System CHOgro Expression System At Mirus Bio, we know it s all about expression. Introducing the new CHOgro Expression System, a transient transfection platform that finally gets high protein titers with robust

More information

Medicyte GmbH. Infinity Gets Cultured. European Business Development Conference, Dresden October 2014 Björn F. Lindemann, CEO

Medicyte GmbH. Infinity Gets Cultured. European Business Development Conference, Dresden October 2014 Björn F. Lindemann, CEO Medicyte GmbH Infinity Gets Cultured European Business Development Conference, Dresden October 2014 Björn F. Lindemann, CEO Medicyte GmbH Founded 2007, privately owned Unique IP protected technology ISO

More information

Scaling Down Bioreactor Process Development: Comparison of Microbioreactor and Bench Scale Solutions.

Scaling Down Bioreactor Process Development: Comparison of Microbioreactor and Bench Scale Solutions. Scaling Down Bioreactor Process Development: Comparison of Microbioreactor and Bench Scale Solutions. Richard Lugg. Scientist I, MedImmune. European Laboratory Robotics Interest Group: High Throughput

More information

Regulatory requirements for early stage clinical trials with cell-based medicinal products. Christopher A Bravery

Regulatory requirements for early stage clinical trials with cell-based medicinal products. Christopher A Bravery Regulatory requirements for early stage clinical trials with cell-based medicinal products Christopher A Bravery cbravery@advbiols.com Opening Remarks Cell-based medicinal products are in themselves diverse,

More information

Regulatory frameworks of regenerative medicines and products review in Japan

Regulatory frameworks of regenerative medicines and products review in Japan Regulatory frameworks of regenerative medicines and products review in Japan August 27th, 2018 Kenji KUROIWA Deputy Director, Medical Devices Evaluation Division Ministry of Health, Labour and Welfare,

More information

Take the Rational Approach of the BalanCD CHO Media Platform

Take the Rational Approach of the BalanCD CHO Media Platform Accelerate your development of therapeutics from discovery to commercialization Take the Rational Approach of the BalanCD CHO Media Platform It takes ambition, dedication, and fortitude to translate a

More information

ABOUT GLYCOSTEM. Company Overview

ABOUT GLYCOSTEM. Company Overview ABOUT GLYCOSTEM The company is a clinical stage biotech company established in the Netherlands in 2007. The company s headquarters and new state-of-the-art lab and production facilities are based at Pivot

More information

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development University of Wisconsin-Madison, Production Assistance for Cellular Therapies (PACT) Over the

More information

Thermo Scientific Metabolic Pathway Design Process Cell culture media and process optimization approaches for optimal biotherapeutic production

Thermo Scientific Metabolic Pathway Design Process Cell culture media and process optimization approaches for optimal biotherapeutic production Thermo Scientific Metabolic Pathway Design Process Cell culture media and process optimization approaches for optimal biotherapeutic production May/June 2013 1 The world leader in serving science Agenda

More information

Protocol for Small-Scale Microcarrier Culture

Protocol for Small-Scale Microcarrier Culture Protocol for Small-Scale Microcarrier Culture Hillex II Microcarriers This document provides a general protocol for initiation of small-scale mammalian cell spinner cultures. This procedure is based upon

More information